Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Knapsack raised $10 million from ...

Getting design and engineering teams on the same page about what digital product to create and how to build it continues to be a challenge. A lot of companies find themselves dealing with scattered ...

Speaker Mike Johnson is not planning to allow Democrats’ newest congresswoman-elect to be sworn-in until her party agrees to end the government shutdown, despite telling CNN earlier Tuesday that he ...

Last night, '90s emo pioneers Knapsack reunited for a show at Soda Bar in San Diego, CA. The one-off show was announced this past June and precedes the band's appearance at Best Friends Festival later ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

Figure 1. Neural networks can store and recall information. In a recall task where the desired output pattern is identical to the input pattern, several patterns can ...

Another name for brute force is exhaustive search. In these algorithms you consider every possible solution in the solution domain to find the optimal solution. Depending on the type of problem that ...